An investment consortium led by Signet Healthcare Partners, Bionpharma, Inc and GMS Capital Partners LLC today announced it has formed Pharma Nobis, LLC (the “Company”) to acquire Fagron’s US contract manufacturing business.
February 4, 2022
· 3 min read